JeanLuc Souche - Amoeba SA B Board

All Insiders France . 
Stock . Amoeba SA . Stakeholders . Insider . JeanLuc Souche
ALMIB Stock  EUR 0.74  0.04  5.13%   

Insider

JeanLuc Souche is B Board of Amoeba SA
Phone33 4 26 69 16 00
Webhttps://amoeba-nature.com

Amoeba SA Management Efficiency

The company has return on total asset (ROA) of (0.2888) % which means that it has lost $0.2888 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.487) %, meaning that it generated substantial loss on money invested by shareholders. Amoeba SA's management efficiency ratios could be used to measure how well Amoeba SA manages its routine affairs as well as how well it operates its assets and liabilities.
Amoeba SA has accumulated 268.74 K in total debt with debt to equity ratio (D/E) of 4.23, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amoeba SA has a current ratio of 2.91, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Amoeba SA until it has trouble settling it off, either with new capital or with free cash flow. So, Amoeba SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amoeba SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amoeba to invest in growth at high rates of return. When we think about Amoeba SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Scott JeffersGensight Biologics SA
N/A
Lionel RigaudBlockchain Group SA
N/A
William LeeGaussin
N/A
Pr RoskaGensight Biologics SA
N/A
Marine GarnierDrone Volt SA
N/A
Charles KremerBlockchain Group SA
N/A
Marc CourcelleDrone Volt SA
56
Clothilde CailletGensight Biologics SA
N/A
Rodolphe CadioBlockchain Group SA
N/A
Maxime VanmeerbeckBlockchain Group SA
N/A
Sylvain NavarroDrone Volt SA
Lia AlmeidaBlockchain Group SA
N/A
Serge PicaudGensight Biologics SA
N/A
Gary PattersonGaussin
57
Bernard BerthierDrone Volt SA
N/A
Alexandre HardouinDrone Volt SA
N/A
Xavier LatilBlockchain Group SA
N/A
JoseAlain MDGensight Biologics SA
N/A
Prof CepkoGensight Biologics SA
N/A
Peggy GerardBlockchain Group SA
N/A
Vincent FerrandBlockchain Group SA
N/A
Amoba S.A. develops and sells biocidal and fungicide products. The company was founded in 2010 and is headquartered in Chassieu, France. AMOEBA is traded on Paris Stock Exchange in France. Amoeba SA (ALMIB) is traded on Euronext Paris in France and employs 18 people.

Management Performance

Return On Equity-3.49
Return On Asset-0.29

Amoeba SA Leadership Team

Elected by the shareholders, the Amoeba SA's board of directors comprises two types of representatives: Amoeba SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amoeba. The board's role is to monitor Amoeba SA's management team and ensure that shareholders' interests are well served. Amoeba SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amoeba SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
JeanBaptiste Eberst, Regulatory Board
JeanLuc Souche, B Board
Fabrice Plasson, CEO, CoFounder
Valerie Filiatre, Member GM
Sandrine Demaneche, Scientific Board

Amoeba Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amoeba SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-3.49
Return On Asset-0.29
Current Valuation40.89 M
Shares Outstanding46.27 M
Shares Owned By Insiders3.25 %
Price To Book10.62 X
Price To Sales412.48 X
Gross Profit(766.61 K)
EBITDA(4.46 M)
Net Income(7.82 M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
TITANTitan Company Limited
UUnity Software
PAYCPaycom Soft

Additional Tools for Amoeba Stock Analysis

When running Amoeba SA's price analysis, check to measure Amoeba SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amoeba SA is operating at the current time. Most of Amoeba SA's value examination focuses on studying past and present price action to predict the probability of Amoeba SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amoeba SA's price. Additionally, you may evaluate how the addition of Amoeba SA to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY